Collaborative virtual reality improves walking
- Trial ID
- NCT07523425
- Official Title
- COMPARATIVE EFFECTIVENESS of COLLABORATIVE VIRTUAL ENVIRONMENT and NON-IMMERSIVE VIRTUAL REALITY in the REHABILITATION of PATIENTS With PARKINSON'S DISEASE
- Goal
- Collaborative virtual reality improves walking
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Superior University
- Study Type
- INTERVENTIONAL
- Enrollment
- 60 participants
- Conditions
- Parkinson Desease
- Interventions
- Collaborative Virtual Environment, Non-Immersive Virtual Reality (NIVR)
Summary For Families
Goal: to see whether a collaborative virtual environment where people work together in the same virtual space improves balance, gait, and everyday motor function more than standard non-immersive, screen-based virtual reality. Approach: participants do guided, task-based exercises using sensors or a screen, the collaborative setup adds social interaction and real-time visual and auditory feedback to boost motor learning, while the non-immersive option gives individual practice; both are rehab tools meant to complement, not replace, stable Parkinson's medications. Eligibility: adults 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages I to III, on stable conventional treatment, with no severe cognitive impairment (MMSE ≥ 24) and able to tolerate virtual sessions, excluding people with severe sensory problems, epilepsy, or other conditions that block participation.
Locations
- Punjab Institute of Neurosciences Lahore, Lahore, Punjab Province, Pakistan
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Collaborative Virtual Environment. Goal: to see whether a collaborative virtual environment where people work together in the same virtual space improves balance, gait, and everyday motor function more than standard non-immersive, screen-based virtual reality. Approach: participants do guided, task-based exercises using sensors or a screen, the collaborative setup adds social interaction and real-time visual and auditory feedback to boost motor learning, while the non-immersive option gives individual practice; both are rehab tools meant to complement, not replace, stable Parkinson's medications. Eligibility: adults 45 to 80 with idiopathic Parkinson's at Hoehn and Yahr stages I to III, on stable conventional treatment, with no severe cognitive impairment (MMSE ≥ 24) and able to tolerate virtual sessions, excluding people with severe sensory problems, epilepsy, or other conditions that block participation.
- Who can participate?
- Participants must be between 45 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year and 4 months.
- Will I get the real drug or a placebo?
- It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
- How often will I need to visit the study site?
- Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Will travel or parking be reimbursed?
- Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.